Findings reported in JAMA Network Open today show more than one-third of infected preschoolers are asymptomatic. The results call into question COVID-19 prevention strategies based on screening young children for symptoms.
Findings reported in JAMA Network Open today show more than a one-third of infected preschoolers are asymptomatic. The results call into question COVID-19 prevention strategies based on screening young children for symptoms.
Preschool-aged children infected with the SARS-CoV-2 virus are frequently asymptomatic and their symptoms are not correlated with viral load, according to the results of a study published today in JAMA Network Open. The results suggest that efforts to control COVID-19 transmission by screening young children for symptoms may be misguided.
An editorial accompanying the study says increasing the number of young children who are vaccinated against COVID-19 is likely the best strategy for reducing transmission in preschool children. In June, the FDA granted an emergency use authorization for the Pfizer and Moderna vaccines in preschool children and CDC’s Advisory Committee on Immunization Practices issued interim recommendation for their use in small children.
Ruth A. Karron, M.D., a professor at Johns Hopkins and an infectious disease researcher, and her colleagues reported results that show that a little over one-third (36.8%) of children, ages 0-4, infected with the SARS-CoV-2 in their study were asymptomatic compared. In contrast, about 1 in 7 (14.3%) of the infected adults in the study were asymptomatic. Karron and her colleagues also found that the number of symptoms was not correlated to viral load among children whereas among but symptoms and viral were correlated among adults.
The study was conducted between Nov. 24, 2020, and Oct. 15, 2021. The omicron variants started circulating in the U.S. in November 2021, so after the eight-month study was completed.
One of the strengths of the study was that it was designed prospectively. The researchers enrolled 175 Maryland households. The households comprised 256 children, ages 0 to 4; 100 children, ages5 to 17, and 334 adults. The participating households filled out weekly questionnaires about possible COVID-19 symptoms and submitted nasal swabs for polymerase chain reaction (PCR) testing that is more reliable that the at-home rapid antigen tests. They also collected blood samples at the beginning, end and mid-way through the study.
Fifty-four (7.8%) of the 690 people in the study experienced SARS-CoV-2 infections.
One of the limitations of the study is that the numbers of infected participants was quite small, especially when they were broken down by age group. For example, the finding that infected young children are more commonly asymptomatic was based a comparison between seven of the 19 infected children in the 0-4 age group to the adult group of 21 infected individuals, three of whom were asymptomatic.
The study also suffered from lack of diversity: 87.4% of the study participants self-reported their race as White.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More